Impact of gastrointestinal differences in veterinary species on the oral drug solubility, in vivo dissolution, and formulation of veterinary therapeutics

Many gaps exist in our understanding of species differences in gastrointestinal (GI) fluid composition and the associated impact of food intake and dietary composition on in vivo drug solubilization. This information gap can lead to uncertainties with regard to how best to formulate pharmaceuticals...

Full description

Bibliographic Details
Main Authors: Marilyn N. Martinez, Mark G. Papich, Raafat Fahmy
Format: Article
Language:English
Published: International Association of Physical Chemists (IAPC) 2022-01-01
Series:ADMET and DMPK
Online Access:https://pub.iapchem.org/ojs/index.php/admet/article/view/1140
_version_ 1818985567468126208
author Marilyn N. Martinez
Mark G. Papich
Raafat Fahmy
author_facet Marilyn N. Martinez
Mark G. Papich
Raafat Fahmy
author_sort Marilyn N. Martinez
collection DOAJ
description Many gaps exist in our understanding of species differences in gastrointestinal (GI) fluid composition and the associated impact of food intake and dietary composition on in vivo drug solubilization. This information gap can lead to uncertainties with regard to how best to formulate pharmaceuticals for veterinary use or the in vitro test conditions that will be most predictive of species-specific in vivo oral product performance. To address these challenges, this overview explores species-specific factors that can influence oral drug solubility and the formulation approaches that can be employed to overcome solubility-associated bioavailability difficulties. These discussions are framed around some of the basic principles associated with drug solubilization, reported species differences in GI fluid composition, types of oral dosage forms typically given for the various animal species, and the effect of prandial state in dogs and cats. This basic information is integrated into a question-and-answer section that addresses some of the formulation issues that can arise in the development of veterinary medicinals.
first_indexed 2024-12-20T18:36:57Z
format Article
id doaj.art-2f2c4b6fa55e4c7ab4e4b863aa86dcda
institution Directory Open Access Journal
issn 1848-7718
language English
last_indexed 2024-12-20T18:36:57Z
publishDate 2022-01-01
publisher International Association of Physical Chemists (IAPC)
record_format Article
series ADMET and DMPK
spelling doaj.art-2f2c4b6fa55e4c7ab4e4b863aa86dcda2022-12-21T19:29:54ZengInternational Association of Physical Chemists (IAPC)ADMET and DMPK1848-77182022-01-0110.5599/admet.1140Impact of gastrointestinal differences in veterinary species on the oral drug solubility, in vivo dissolution, and formulation of veterinary therapeuticsMarilyn N. Martinez0Mark G. Papich1Raafat Fahmy2Office of New Animal Drug Evaluation, Center for Veterinary Medicine, US Food and Drug Administration, Rockville, Maryland, USA2College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USAOffice of New Animal Drug Evaluation, Center for Veterinary Medicine, US Food and Drug Administration, Rockville, Maryland, USAMany gaps exist in our understanding of species differences in gastrointestinal (GI) fluid composition and the associated impact of food intake and dietary composition on in vivo drug solubilization. This information gap can lead to uncertainties with regard to how best to formulate pharmaceuticals for veterinary use or the in vitro test conditions that will be most predictive of species-specific in vivo oral product performance. To address these challenges, this overview explores species-specific factors that can influence oral drug solubility and the formulation approaches that can be employed to overcome solubility-associated bioavailability difficulties. These discussions are framed around some of the basic principles associated with drug solubilization, reported species differences in GI fluid composition, types of oral dosage forms typically given for the various animal species, and the effect of prandial state in dogs and cats. This basic information is integrated into a question-and-answer section that addresses some of the formulation issues that can arise in the development of veterinary medicinals.https://pub.iapchem.org/ojs/index.php/admet/article/view/1140
spellingShingle Marilyn N. Martinez
Mark G. Papich
Raafat Fahmy
Impact of gastrointestinal differences in veterinary species on the oral drug solubility, in vivo dissolution, and formulation of veterinary therapeutics
ADMET and DMPK
title Impact of gastrointestinal differences in veterinary species on the oral drug solubility, in vivo dissolution, and formulation of veterinary therapeutics
title_full Impact of gastrointestinal differences in veterinary species on the oral drug solubility, in vivo dissolution, and formulation of veterinary therapeutics
title_fullStr Impact of gastrointestinal differences in veterinary species on the oral drug solubility, in vivo dissolution, and formulation of veterinary therapeutics
title_full_unstemmed Impact of gastrointestinal differences in veterinary species on the oral drug solubility, in vivo dissolution, and formulation of veterinary therapeutics
title_short Impact of gastrointestinal differences in veterinary species on the oral drug solubility, in vivo dissolution, and formulation of veterinary therapeutics
title_sort impact of gastrointestinal differences in veterinary species on the oral drug solubility in vivo dissolution and formulation of veterinary therapeutics
url https://pub.iapchem.org/ojs/index.php/admet/article/view/1140
work_keys_str_mv AT marilynnmartinez impactofgastrointestinaldifferencesinveterinaryspeciesontheoraldrugsolubilityinvivodissolutionandformulationofveterinarytherapeutics
AT markgpapich impactofgastrointestinaldifferencesinveterinaryspeciesontheoraldrugsolubilityinvivodissolutionandformulationofveterinarytherapeutics
AT raafatfahmy impactofgastrointestinaldifferencesinveterinaryspeciesontheoraldrugsolubilityinvivodissolutionandformulationofveterinarytherapeutics